Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nab-paclitaxel”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06611150
What this trial is testing

Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07763496
What this trial is testing

Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
ARCAGY/ GINECO GROUP 63
Early research (Phase 1)Study completedNCT02798536
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma

Who this might be right for
Mesothelioma
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Looking for participantsNCT06906341
What this trial is testing

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms+1 more
Corcept Therapeutics 270
Testing effectiveness (Phase 2)UnknownNCT03919253
What this trial is testing

Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study

Who this might be right for
HER2-positive Breast Cancer
Hebei Medical University Fourth Hospital 80
Early research (Phase 1)Study completedNCT00732836
What this trial is testing

Hepatic Arterial Infusion (HAI) of Abraxane

Who this might be right for
Liver CancerAdvanced CancersSolid Tumors
M.D. Anderson Cancer Center 64
Not applicableStudy completedNCT01689610
What this trial is testing

Non-interventional Study With Nab-Paclitaxel (Abraxane®)

Who this might be right for
Metastatic Breast Cancer
iOMEDICO AG 705
Testing effectiveness (Phase 2)Ended earlyNCT02598310
What this trial is testing

Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor Negative NeoplasmHER-2 Positive Breast Cancer
Osaka Medical College 30
Not applicableStudy completedNCT01442974
What this trial is testing

Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Grupo Hospital de Madrid 15
Testing effectiveness (Phase 2)Study completedNCT00093223
What this trial is testing

A Safety Study of ABI-007 for In-Stent Restenosis

Who this might be right for
Angina PectorisCoronary Artery Disease
Celgene 76
Testing effectiveness (Phase 2)Ended earlyNCT02075021
What this trial is testing

Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
NYU Langone Health 3
Testing effectiveness (Phase 2)Study completedNCT07719738
What this trial is testing

Bevacizumab Plus Nab-paclitaxel and Tegafur Gimeracil Oteracil Potassium Capsule (S-1) as Second-line Treatment for Advanced Biliary Tract Cancer: a Phase Ⅱ Clinical Trial

Who this might be right for
Biliary Cancer Metastatic
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 32
Early research (Phase 1)Study completedNCT01010945
What this trial is testing

Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
OSI Pharmaceuticals 19
Not applicableUnknownNCT04017377
What this trial is testing

VMAT Concurrent Cisplatin Plus Nab-paclitaxel for Local Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Peking University Third Hospital 15
Large-scale testing (Phase 3)Study completedNCT00046527
What this trial is testing

Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsMetastases, Neoplasm
Celgene Corporation 460
Large-scale testing (Phase 3)Looking for participantsNCT06438627
What this trial is testing

Efficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A Phase 3 Trial

Who this might be right for
Nasopharyngeal Carcinoma
XIANG YANQUN 164
Very early researchStudy completedNCT02550327
What this trial is testing

Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
Baylor Research Institute 20
Testing effectiveness (Phase 2)Looking for participantsNCT04138719
What this trial is testing

Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer

Who this might be right for
Breast CancerTriple-negative Breast CancerNab-paclitaxel
Hebei Medical University Fourth Hospital 520
Large-scale testing (Phase 3)Looking for participantsNCT06361888
What this trial is testing

A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Hutchmed 502
Large-scale testing (Phase 3)Study completedNCT04083235
What this trial is testing

Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

Who this might be right for
Metastatic Adenocarcinoma of the Pancreas
Ipsen 770
Next Page